Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A groundbreaking SAMRC study has uncovered significant underreporting of HIV-related deaths in South Africa, despite the ...

However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...

One of the hot topics at this year's Conference on Retroviruses and Opportunistic Infections will be long COVID: potential ...